PRESS RELEASE published on 02/03/2026 at 15:42, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation The Vanguard Group, Inc. discloses a 10.91% stake in Dauch Corporation with relevant securities holdings. Details of dealings and positions disclosed Investment The Vanguard Group Financial Disclosure Stock Holdings Dauch Corporation
PRESS RELEASE published on 02/03/2026 at 15:42, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 5.07% ownership in JTC plc as of 02 Feb 2026. Purchase of 3,420 securities at 12.91 GBP per unit The Vanguard Group Ownership Disclosure Financial Disclosure Securities Purchase JTC Plc
PRESS RELEASE published on 02/03/2026 at 15:41, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Glencore plc The Vanguard Group, Inc. discloses 4.89% interest in Glencore plc's securities. Also involved with Rio Tinto plc and Limited. Purchase and sale transactions reported Securities Transactions Vanguard Group Rio Tinto Glencore Plc
PRESS RELEASE published on 02/03/2026 at 15:40, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.94% ownership in Avadel Pharmaceuticals plc. Details in Form 8.3 submitted to the Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Ownership Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 02/03/2026 at 15:39, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.02% ownership in Beazley plc through Form 8.3. Purchase of 5p ordinary shares made at 11.68 GBP per unit on 02 Feb 2026 The Vanguard Group, Inc. Form 8.3 Ownership Disclosure Share Purchase Beazley Plc
PRESS RELEASE published on 02/03/2026 at 15:39, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.58% stake in Spire Healthcare Group plc through Form 8.3 filing. Purchase of 5,646 securities made at 2.08 GBP per unit Form 8.3 Vanguard Group Spire Healthcare Stake Disclosure Securities Purchase
PRESS RELEASE published on 02/03/2026 at 15:38, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses a relevant securities position relating to Dowlais Group plc under Rule 8.3 of the Takeover Code Rule 8.3 Vanguard Group Inc. Takeover Code Securities Position Dowlais Group Plc
PRESS RELEASE published on 02/03/2026 at 15:37, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 4.93% stake in Just Group plc on 02/02/2026 in compliance with Rule 8.3 of the Takeover Code The Vanguard Group, Inc. Rule 8.3 Takeover Code Stake Disclosure Just Group Plc
PRESS RELEASE published on 02/03/2026 at 15:36, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses a 5.25% stake in Picton Property Income Limited on 02 Feb 2026. Details of current positions revealed via Form 8.3 Securities Form 8.3 Vanguard Group Stake Disclosure Picton Property Income Limited
PRESS RELEASE published on 02/03/2026 at 15:35, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.69% interest in NCC Group plc in a Form 8.3 filing under the Takeover Code Form 8.3 Disclosure Takeover Code Vanguard Group NCC Group Plc
Published on 09/12/2026 at 02:35, 1 day 6 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 10 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 11 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 16 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 15 hours 22 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 1 hour ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 10 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 11 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 13 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 2 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 2 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 13 hours ago Availability of the 2026 Interim Financial Report
